SYNEDGEN, INC.

Company Information

Company Name
SYNEDGEN, INC.
Address
SYNEDGEN, INC.
1420 N CLAREMONT BLVD, STE 105D
CLAREMONT, CA, 91711-3583
Phone
n/a
URL
http://www.synedgen.com
DUNS
830276353
Number of Employees
10
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$695,815.00
5
SBIR Phase II
$2,834,356.00
2

Award List

  1. Wound Decontamination for the Prevention and Treatment of Multi-drug Resistant Ba

    Amount: $99,638.00

    DESCRIPTION (provided by applicant): The frequency of multi-drug resistant infections is increasing at an alarming rate. Equally concerning is the limited therapeutic options available for effective t ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. Prevention and Treatment of Oral Biofilms and Related Oral Disease by Soluble Chi

    Amount: $99,665.00

    DESCRIPTION (provided by applicant): A need remains for safe and effective, prophylactic and therapeutic treatments for controlling bacterial populations in dental plaque and treating periodontal dis ...

    SBIR Phase I 2009 Department of Health and Human Services
  3. Antimicrobial and Regenerative Treatment for Oral Mucositis

    Amount: $1,963,826.00

    DESCRIPTION (provided by applicant): Oral mucositis is a frequent and painful complication of chemotherapy, radiotherapy and immune compromise. Mucositis is associated with significant morbidity incl ...

    SBIR Phase II 2011 Department of Health and Human Services
  4. Effective New Topical Treatment to Reduce Scar Formation in Burns

    Amount: $149,904.00

    Thermal injury is common in military conflicts due to primarily to the widespread use of explosive devices. Burns can produce scars that are excessive, physically debilitating and functionally damagin ...

    SBIR Phase I 2013 Department of Defense
  5. Rectal Medication Administration Device for Palliative Care

    Amount: $149,901.00

    DESCRIPTION (provided by applicant): Thick hyperviscous mucus and delayed mucociliary clearance are important elements underlying cystic fibrosis (CF) pathogenesis, but currently available therapeutic ...

    SBIR Phase I 2013 Department of Health and Human Services
  6. Effective New Topical Treatment to Reduce Scar Formation in Burns

    Amount: $870,530.00

    Thermal injury is common in military conflicts due primarily to the widespread use of explosive devices. Though scar formation is a natural process of wound healing, burns can produce scars that are e ...

    SBIR Phase II 2014 Defense Health ProgramDepartment of Defense
  7. Clinical Development of IPdR for Radiosensitization Period of Performance: 09/19/2014- 06/18/2015

    Amount: $196,707.00

    Radiotherapy is a well-established treatment for cancer, however pelvic radiotherapy can result in radiation proctitis, particularly after treatment of prostate or cervical cancer. In severe cases, ra ...

    SBIR Phase I 2014 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government